Mechanisms underlying agonist efficacy

Biochemical Society Transactions

Volumn 35, Issue 4, 2007, Pages 733-736

  Strange, P G ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Agonist efficacy; D2 dopamine receptor; G protein cycle; G protein coupled receptor (GPCR); Guanosine 5 35S thio triphosphate binding assay ( 35S GTP S binding assay); Kinetics

Indexed keywords

DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANOSINE TRIPHOSPHATE;

BINDING ASSAY; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; IN VITRO STUDY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 34548148009     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0350733     Document Type: Conference Paper

References (27)

1. Ohlsen, R.I. and Pilowsky, L.S. (2005) J. Psychopharmacol. 19, 408-413
2. Hoffmann, C., Gaietta, G., Bunemann, M., Adams, S.R., Oberdorff-Maass, S., Behr, B., Vilardaga, J.P., Tsien, R.Y., Ellisman, M.H. and Lohse, M.J. (2005) Nat. Methods 2, 171-176
3. Gardner, B. and Strange, P.G. (1998) Br. J. Pharmacol. 124, 978-984
4. Gardner, B.R., Hall, D.A. and Strange, P.G. (1997) J. Neurochem. 69, 2589-2598
5. Black, J.W. and Leff, P. (1983) Proc. R. Soc. London Ser. B 220, 141-162
6. Trzeciakowski, J.P. (1999) J. Theor. Biol. 198, 329-346
7. Harrison, C. and Traynor, J.R. (2003) Life Sci. 74, 489-508
8. Birnbaumer, L., Abramowitz, J. and Brown, A.M. (1990) Biochim. Biophys. Acta 1031, 163-224
9. Labrecque, J., Anastassov, V., Lau, G., Darkes, M., Mosi, R. and Fricker, S.P. (2005) Assay Drug Dev. Technol. 3, 637-648
10. Milligan, G. (2003) Trends Pharmacol. Sci. 24, 87-90
11. Selley, D.E., Sim, L.J., Xiao, R., Liu, Q. and Childers, S.R. (1997) Mol. Pharmacol. 51, 87-96
12. Breivogel, C.S., Selley, D.E. and Childers, S.R. (1998) J. Biol. Chem. 273, 16865-16873
13. Lazareno, S., Farries, T. and Birdsall, N.J. (1993) Life Sci. 52, 449-456
14. Mueller, A., Mahmoud, N.G., Goedecke, M.C., McKeating, J.A. and Strange, P.G. (2002) Br. J. Pharmacol. 135, 1033-1043
15. Gardner, B., Hall, D.A. and Strange, P.G. (1996) Br. J. Pharmacol. 118, 1544-1550
16. Roberts, D.J., Lin, H. and Strange, P.G. (2004) Biochem. Pharmacol. 67, 1657-1665
17. Payne, S.L., Johansson, A.M. and Strange, P.G. (2002) J. Neurochem. 82, 1106-1117
18. Lin, H., Saisch, S.G. and Strange, P.G. (2006) Br. J. Pharmacol. 149, 291-299
19. Roberts, D.J. and Strange, P.G. (2005) Br. J. Pharmacol. 145, 34-42
20. McLoughlin, D.J. and Strange, P.G. (2000) J. Neurochem. 74, 347-357
21. Lahti, R.A., Figur, L.M., Piercey, M.F., Ruppel, P.L. and Evans, D.L. (1992) Mol. Pharmacol. 42, 432-438
22. Roberts, D.J., Lin, H. and Strange, P.G. (2004) Mol. Pharmacol. 66, 1573-1579
23. Otero, A.D. (1990) Biochem. Pharmacol. 39, 1399-1404
24. Jinnah, H.A., Page, T. and Friedmann, T. (1993) J. Neurochem. 60, 2036-2045
25. Selley, D.E., Liu, Q. and Childers, S.R. (1998) J. Pharmacol. Exp. Ther. 285, 496-505
26. Ruffolo, Jr, R.R. and Waddell, J.E. (1983) J. Pharmacol. Exp. Ther. 224, 559-566
27. Quirk, K., Roberts, D.J. and Strange, P.G. (2007) Br. J. Pharmacol. 151, 144-152